SkinHealth Systems Inc. Class A's next confirmed earnings release is scheduled for March 17, 2027.
| Earnings Date | 3/17/2027 |
As of September 30, 2026, SkinHealth Systems Inc. Class A has 6.51M shares outstanding.
| Shares Outstanding | 6.51M |
As of September 30, 2026, SkinHealth Systems Inc. Class A maintains a current ratio of 2.89, meaning it holds 2.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 473.92, indicating elevated leverage, while an interest coverage ratio of 1.11 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.89 |
| Quick Ratio | 1.90 |
| Debt / Equity | 473.92 |
| Debt / EBITDA | 9.39 |
| Interest Coverage | 1.11 |
Over the twelve months ended September 30, 2026, SkinHealth Systems Inc. Class A posted a negative return on equity (ROE) of -30.13, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -4.10, reflecting losses generated across the asset base. The company generates approximately 415,331.57 in revenue per employee across its workforce of 613.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.85 indicates how many times SkinHealth Systems Inc. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -30.13 |
| Return on Assets (ROA) | -4.10 |
| Revenue Per Employee | 415,331.57 |
| Employee Count | 613.00 |
| Inventory Turnover | 1.85 |
Over the twelve months ended September 30, 2026, SkinHealth Systems Inc. Class A recorded 4.50M in income tax expense. The company reported a pretax loss of -11.64M and -16.14M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | 4.50M |
Over the twelve months ended September 30, 2026, SkinHealth Systems Inc. Class A generated 254.60M in revenue and converted that into -16.14M in net income, yielding earnings per share of -2.49. EBITDA reached 24.83M, while operating income came in at 6.10M.
| Revenue | 254.60M |
| Gross Profit | 171.13M |
| Operating Income | 6.10M |
| Pretax Income | -11.64M |
| Net Income | -16.14M |
| EBITDA | 24.83M |
| EBIT | 6.10M |
| Earnings Per Share (EPS) | -2.49 |
As of September 30, 2026, SkinHealth Systems Inc. Class A holds 99.16M in cash and equivalents against 233.14M in total debt, resulting in a net debt position of 115.21M. Total book value stands at 49.19M, with working capital of 116.24M providing operational flexibility.
| Cash & Cash Equivalents | 99.16M |
| Total Debt | 233.14M |
| Net Debt | 115.21M |
| Equity (Book Value) | 49.19M |
| Book Value Per Share | 7.56 |
| Working Capital | 116.24M |
SkinHealth Systems Inc. Class A produced 20.80M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -4.68M in capital expenditures, free cash flow totaled 16.13M - equivalent to 2.50 per share.
| Operating Cash Flow | 20.80M |
| Capital Expenditures | -4.68M |
| Free Cash Flow | 16.13M |
| FCF Per Share | 2.50 |
Over the twelve months ended September 30, 2026, SkinHealth Systems Inc. Class A posted a gross margin of 67.22, reflecting its pricing power and cost economics. The operating margin of 2.39 and net profit margin of -6.34 provide insight into operational efficiency.
| Gross Margin | 67.22 |
| Operating Margin | 2.39 |
| Pretax Margin | -4.57 |
| Profit Margin | -6.34 |
| EBITDA Margin | 9.75 |
SkinHealth Systems Inc. Class A's most recent stock split took place on October 14, 2026 with a 20:1 split ratio.
| Last Split Date | 10/14/2026 |
| Split Ratio | 20:1 |